Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : EntreMed (ENMD) -- Ignore unavailable to you. Want to Upgrade?

To: LTK007 who wrote (578)	5/4/1998 8:01:00 PM
From: dwight martin	Respond to of 2135

There will be a segment on ENMD's -statins on McNeil-Lehrer (PBS news) tonite.

To: LTK007 who wrote (578)	5/4/1998 8:27:00 PM
From: Sam Citron	Read Replies (1) \| Respond to of 2135

Max, Yes, a National Cancer Institute spokesman appeared tonight on McNeil Lehrer (PBS). He said that it would probably take about a year to ramp production up to have enough of the drug to begin Phase 1 clinical trials. These trials will take several more years. Sounded like even if everything went perfectly it may take 4-5 years for the drug to be approved for sale. And he said there have been many medicines that cured mice that did not cure humans. But he is "cautiously optimistic". I doubt that those who placed market orders to buy ENMD at today's opening will patiently stand by for the next 5 years. SC